1. Home
  2. NABL vs ZVRA Comparison

NABL vs ZVRA Comparison

Compare NABL & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo N-able Inc.

NABL

N-able Inc.

HOLD

Current Price

$4.14

Market Cap

761.3M

Sector

Technology

ML Signal

HOLD

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

HOLD

Current Price

$11.36

Market Cap

689.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NABL
ZVRA
Founded
2000
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
761.3M
689.4M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
NABL
ZVRA
Price
$4.14
$11.36
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
$8.31
★ $23.00
AVG Volume (30 Days)
★ 2.3M
741.3K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 159.21
EPS
N/A
★ 0.74
Revenue
★ $511,430,000.00
$106,470,000.00
Revenue This Year
$11.04
$37.27
Revenue Next Year
$8.53
$53.42
P/E Ratio
★ N/A
$15.31
Revenue Growth
9.71
★ 350.91
52 Week Low
$2.92
$8.01
52 Week High
$8.74
$15.04

Technical Indicators

Market Signals
Indicator
NABL
ZVRA
Relative Strength Index (RSI) 52.79 43.43
Support Level $3.81 $10.81
Resistance Level $4.24 $12.19
Average True Range (ATR) 0.21 0.38
MACD 0.01 -0.09
Stochastic Oscillator 69.07 30.53

Price Performance

Historical Comparison
NABL
ZVRA

About NABL N-able Inc.

N-able Inc is a provider of cloud-based software solutions for managed service providers (MSPs), enabling them to support digital transformation and growth for small and medium-sized enterprises. With a flexible technology platform and powerful integrations, N-able makes it easy for MSPs to monitor, manage, and protect their end-customer systems, data, and networks. The company's growing portfolio of management, security, automation, and data protection solutions is built for IT services management professionals. Geographically, the majority of revenue is from the United States. The company also has a presence in the United Kingdom and all other International regions.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

Share on Social Networks: